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Background: Imported bancroftian ﬁlariasis (IBF) caused by
Wuchereria bancrofti (Wb) in crossborder Myanmar migrant
workers has been targeted for multidose diethylcarbamazine
(DEC) mass treatment as part of the lymphatic ﬁlariasis elimina-
tion program at different health settings in permitted provinces.
Regarding their healthseeking behaviors and migration patterns,
the IBF was scrutinized for a 300mg single-dose DEC response and
benzimidazole-susceptible parasite inhabiting Myanmar carriers
in southern Thailand.
Methods: Of the 1,133 Myanmars: DEC experienced long-termmi-
grants signiﬁcantly outnumbering those shortterm migrants were
examined for microﬁlaremia (WbMf) and antigenemia (WbAg),
parasite loads of 14 DEC-treated antigenemic cases: the same 7
microﬁlaremic and amicroﬁlaremic were monitored at month 0,
1, 2 and 3 to signify DEC treatment effects on infection intensity
reduction. PCR and sequencing of βετα-tubulin gene retained in
7 WbMf isolates were performed to analyze two discrete ex-
ons linked with benzimidazole selection: 141bp (Phe167Tyr) and
174bp amplicons (Phe200Tyr).
Results: Signiﬁcant 3-month antigen load reduction between the
groups was pronounced (Table 1). In microﬁlaremic group, Mf
density rebounded up to pretreatment level whereas parasite
load (WbMf and WbAg) reduction did not correlate with time.
Sequence analysis revealed homology of the fragments (Fig. 1)
against ﬁlarial homologs deposited in genome databases, which
neither point mutation was detected in all isolates.
Conclusion: The IBF predominantly susceptible to benzimidazole
was sensitive to DEC that is still a best-buy public health in-
Fig. 1 Agarose gel electrophoresis of human and W. bancrofti β-tubulin gene
ampliﬁcation. A representative Mf+/Ag+ gDNA template shows a nested PCR
pattern with the Wbtubb primers: lane 1, 607-bp amplicons of the 1st round
PCR; lanes 2 and 3, 141 and 174 bp amplicons of the 2nd round PCR; lane 5,
no gDNA; lane M, the 100-bp DNA ladder as molecular weight marker. A
210-bp fragment conﬁned in lane 4 was yielded by following a single PCR
instead using the Hstubb primers. Two latter exons (Gly132 to Lys174 and
Val175 to Leu228) were 98-100% homologous to putative conserved domain
of the ﬁlarial orthologs, which neither point mutation at position Phe167Tyr
nor Phe200Tyr was detected.
Table 1. Serological response to a 300 mg single oral-dose DEC in the W.
bancrofti antigenemic subjects, before and after treatment (months)
Group† GM Ag load (AU/ml)
0 1 2 3
Mf+/Ag+ (n=7) 137090 121663 116049‡ 113345
Mf–/Ag+ (n=7) 84500 71958 57895‡ 58799
Total antigenemics (n=14) 107630 93567 81968 81637
Ag+ = antigenemic, Ag = antigen, AU/ml = antigen units per milliliters, GM =
geometric mean, Mf– = amicroﬁlaremic, Mf+ = microﬁlaremic.
Signiﬁcant for two-independent samples: all months†, F = 6.147, p = 0.029;
month 2‡, F = 8.375, p = 0.013.
tervention for large-scale controlling its burden in Thailand but
required for both countries important vigilance of the refugia
parasite.
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Many researchers have indicated the correlation between the
prevalence of giardiasis and the quality of tap water puriﬁ-
cation. Industrial toxicants’ contamination may lead to the
pathomorphism of lambliasis infection, immunosuppression and
an increase in occurrence of side effects of antiparasitic drugs.
Objectives: To substantiate the necessity of application of drugs
with minimal resorptive and toxic effects in treatment of children
with giardiasis and evaluate the clinical efﬁcacy of nifuroxazide.
A clinical trial was carried out in 1098 children (aged 1-18
years) with giardiasis. We are analyzed cause-and-effect rela-
tionships between the parameters of biochemical, immunolog-
ical, hormonal homeostasis and the level of xenobiotic load.
The study detected adverse effects of xenobiotics (manganese,
lead, nickel, chromium, acetaldehyde, formaldehyde, acetone,
etc.) on the liver function of deintoxication, their ability to
cause the immune system disorders and tension of the humoral
status. To efﬁciently eradicate the causative agent the authors
applied nifuroxazide (“Enterofuril” Bosnalijek) with no resorp-
tive effect. 38 children received enterosorbents, cholagogues
and nifuroxazide (“Enterofuril” Bosnalijek) at doses of 100-200
mg as a suspension (liquid) 4 times per day (depending on age)
for 7 days. Check analyses of stool samples were performed
in 3-7 days after treatment. The application of nifuroxazide
lead to 100% eradication of the parasite, no side effects were
observed in the children. The application of nifuroxazide in
patients with giardiasis living under conditions of high risk of
biomedia’s contamination by industrial toxicants is pathogenet-
ically substantiated. Nifuroxazide has a signiﬁcant eradication
ability.
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Introduction: Helicobacter pylori (HP) gastritis is a global threat
for gastric carcinoma. We evaluated Levoﬂoxacin, Omeprazole,
Alinia (nitazoxanide) and Doxycycline (LOAD) versus Lansopra-
zole, Amoxicillin and Clarithromycin (LAC) in treatment naive HP
population.
Methods: 135 patients with HP gastritis or peptic ulcers were
enrolled. Age: 18-65 years; Male - 75 (55.55%), female - 60
